The Epstein-Barr virus encoded latent infection membrane protein 1 (LMP1) regulates the processing of p100 NK-κB2 to p52 via an IKKγ/NEMO-independent signaling pathway

Aristides Eliopoulos, Jorge Caamano, Joanne Gough, Gary Reynolds, Paul Murray, JL Poyet, Lawrence Young

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The oncogenic Epstein - Barr virus (EBV)-encoded latent infection membrane protein 1 (LMP1) constitutively activates the 'canonical' NF-kappaB pathway that involves the phosphorylation and degradation of IkappaBalpha downstream of the IkappaB kinases (IKKs). In this study, we show that LMP1 also promotes the proteasome-mediated proteolysis of p100 NF-kappaB2 resulting in the generation of active p52, which translocates to the nucleus in complex with the p65 and RelB NF-kappaB subunits. LMP1-induced NF-kappaB transactivation is reduced in nf-kb2(-/-) mouse embryo fibroblasts, suggesting that p100 processing contributes to LMP1-mediated NF-kappaB transcriptional effects. This pathway is likely to operate in vivo, as the expression of LMP1 in primary EBV-positive Hodgkin's lymphoma and nasopharyngeal carcinoma biopsies correlates with the nuclear accumulation of p52. Interestingly, while the ability of LMP1 to activate the canonical NF-kappaB pathway is impaired in cells lacking IKKgamma/NEMO, the regulatory subunit of the IKK complex, p100 processing remains unaffected. As a result, nuclear translocation of p52, but not p65, occurs in the absence of IKKgamma. These data point to the existence of a novel signalling pathway that regulates NF-kappaB in LMP1-expressingcells, and may thereby play a role in both oncogenic transformation and the establishment of persistent EBV infection.
Original languageEnglish
Pages (from-to)7557-7569
Number of pages13
JournalOncogene
Volume22
Issue number48
DOIs
Publication statusPublished - 23 Oct 2003

Keywords

  • LMP1
  • NF-kappa B2
  • EBV
  • signalling

Fingerprint

Dive into the research topics of 'The Epstein-Barr virus encoded latent infection membrane protein 1 (LMP1) regulates the processing of p100 NK-κB2 to p52 via an IKKγ/NEMO-independent signaling pathway'. Together they form a unique fingerprint.

Cite this